Skip to main content
OpenTrials
Completed

NCT Number: NCT01762267

Effects of DASH Diet on Corticosteroids Medication Use

To determine the effects of the Dietary Approaches to Stop Hypertension (DASH) diet on the metabolic side effects of corticosteroids medications use.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Nutritional and Metabolic Disease Metabolic Diseases Nutritional and Metabolic Diseases

Age range

27 year–35 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 3

Primary location

1. Department of Community Nutrition, School of Nutrition & Food Science, Isfahan University of Medical Science

Isfahan, Iran

About this study

Objective: To determine the effects of the Dietary Approaches to Stop Hypertension (DASH) diet on the metabolic side effects of corticosteroids medications use.

Design: A randomized clinical trial was undertaken in 60 patients on corticosteroid therapy for 10 weeks. Patients were randomly assigned to a DASH or control diet. Fasting blood sample were measured to determine blood glucose and lipid profile. Blood pressure and anthropometric measurements were measured based on the standard guidelines.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients who were on corticosteroid therapy

Exclusion criteria

  • refuse to follow the visits

Treatment and study plan

Nutrition Intervention

Other

DASH diet control diet

Primary outcomes

  1. the amount of weight reduction and change of blood pressure

    Time frame: up to 10 weeks

    weight (kg) body mass index (kg/m2) blood pressure (mmHg)

Secondary outcomes

  1. lipid profile, fasting blood glucose

    Time frame: 10 weeks

    measurement of LDL-C (mg/dl), HDL-C (mg/dl), triglyceride (mg/dl), total cholesterol (mg/dl), fasting blood glucose(mg/dl), by the analysis of blood samples and blood pressure(mmHg) and weight (kg), waist circumference (cm), body mass index (kg/m2).

Other outcomes

  1. lipid profile (mg/dl), fasting blood glucose (mg/dl), blood pressure (mmHg), weight reduction (kg)

    Time frame: july

Sponsors and collaborators

Lead sponsor

Isfahan University of Medical Sciences

Other

Registry information

Official study title

Phase 3 Study of Beneficiary Effects of Dietary Approaches to Stop Hypertension (DASH) on the Metabolic Aeffects of Corticosteroids Medications Use

Important dates

Study start
2011
Primary completion
2012
Study completion
2012
First posted
Jan 7, 2013
Registry last updated
Jan 7, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.